1/2 – Pediatric Prehospital Airway Resuscitation Trial

1/2 — 儿科院前气道复苏试验

基本信息

  • 批准号:
    10738581
  • 负责人:
  • 金额:
    $ 190.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY We aim to answer the signature question of paramedic care; “What is the best way to manage the prehospital airway in critically ill children?” Cardiac arrest, respiratory failure, and major trauma are devastating critical conditions in children. Resuscitation from critical illness requires skillful airway management to optimize delivery of oxygen to the lungs, preventing irreparable damage to the brain and heart. As the first to provide critical care, prehospital paramedics often perform life-saving airway management on critically ill children. The most common prehospital airway management techniques (bag-valve-mask ventilation (BVM), endotracheal intubation (ETI), and supraglottic airway insertion (SGA) have important trade- offs between risks and benefits; the best approach is unknown. We propose the novel Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART) to determine the best strategies for prehospital airway management in critically ill children. Pedi-PART will immediately influence paramedic practices and have a lasting impact upon the health of children internationally. We will determine the relative effectiveness of three airway strategies ([BVM-only], [BVM+ETI], [BVM+SGA]), accounting for variations across disease (cardiac arrest, trauma, respiratory failure) and age categories, and we will apply adaptive techniques to minimize the required number of patients. Our aims are: AIM I: Prepare the Pediatric Emergency Care Applied Research Network (PECARN) to execute the innovative Pedi-PART trial. PECARN is the nation’s premier pediatric emergencies research network. We have assembled an alliance of over 60 EMS agencies from 10 communities associated with PECARN and their ongoing Pediatric Dose Optimization for Seizures in EMS trial (PediDOSE - U01-NS114042). AIM II: Compare the effectiveness of prehospital BVM, SGA, and ETI airway management strategies upon pediatric cardiac arrest, major trauma, and respiratory failure outcomes. We will execute the trial in two sequential stages. Stage I: Determine if [BVM-only] or [BVM followed by SGA] results in better ICU-free survival in critically ill children with cardiac arrest, major trauma, or respiratory failure. Stage II: Determine if [winner of Stage I] or [BVM followed by ETI] results in better ICU-free survival. AIM III: Compare the safety of prehospital BVM, SGA, and ETI airway management strategies in pediatric cardiac arrest, major trauma, and respiratory failure. In Stage I, we will determine if [BVM+SGA] results in fewer prehospital and hospital adverse events compared with [BVM-only] in critically ill children with cardiac arrest, major trauma, or respiratory failure. In Stage II, we will determine if the winner of Stage I results in fewer adverse events compared with [BVM+ETI].
项目概要 我们的目标是回答护理人员护理的标志性问题; “最好的管理方式是什么? 危重儿童院前气道?心脏骤停、呼吸衰竭和严重外伤 儿童的毁灭性危急状况。危重病复苏需要熟练的气道 优化向肺部输送氧气的管理,防止对大脑造成不可挽回的损害 心。作为第一个提供重症监护的人员,院前护理人员经常进行挽救生命的气道管理 对危重儿童。最常见的院前气道管理技术(球袋-阀门-面罩) 通气 (BVM)、气管插管 (ETI) 和声门上气道插入 (SGA) 具有重要的权衡 风险与收益之间的偏差;最好的方法尚不清楚。 我们提出新颖的儿科院前气道复苏试验 (Pedi-PART) 来确定 危重儿童院前气道管理的最佳策略。 Pedi-PART 将 立即影响护理人员的做法并对儿童的健康产生持久的影响 国际上。我们将确定三种气道策略的相对有效性([仅 BVM]、[BVM+ETI]、 [BVM+SGA]),考虑了疾病(心脏骤停、创伤、呼吸衰竭)和年龄的变化 类别,我们将应用适应性技术来尽量减少所需的患者数量。我们的目标是: 目标 I:准备儿科紧急护理应用研究网络 (PECARN) 以执行 创新的 Pedi-PART 试验。 PECARN 是美国首屈一指的儿科紧急情况研究网络。我们 组建了一个由来自 10 个与 PECARN 相关社区的 60 多个 EMS 机构组成的联盟及其 正在进行的 EMS 试验中针对癫痫发作的儿科剂量优化 (PediDOSE - U01-NS114042)。 AIM II:比较院前 BVM、SGA 和 ETI 气道管理策略的有效性 儿童心脏骤停、重大创伤和呼吸衰竭结果。我们将在 两个连续的阶段。第一阶段:确定[仅使用 BVM] 或 [BVM 后加 SGA] 是否会带来更好的免 ICU 效果 心脏骤停、严重创伤或呼吸衰竭的危重儿童的生存率。第二阶段:确定是否 [第一阶段的获胜者]或[BVM,随后是ETI]可带来更好的无ICU生存率。 目标 III:比较院前 BVM、SGA 和 ETI 气道管理策略的安全性 小儿心脏骤停、重大创伤和呼吸衰竭。在第一阶段,我们将确定是否[BVM+SGA] 与[仅 BVM] 相比,对于患有以下疾病的危重儿童,院前和院内不良事件较少 心脏骤停、重大创伤或呼吸衰竭。在第二阶段,我们将决定第一阶段的获胜者是否取得成绩 与 [BVM+ETI] 相比,不良事件更少。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Henry E. Wang其他文献

Managing the airway during cardiac arrest.
心脏骤停期间管理气道。
Prehospital endotracheal intubation: the controversy continues (Conference Proceedings).
院前气管插管:争议仍在继续(会议记录)。
The challenge of defining the "science" of airway management--what is the right outcome measure?
定义气道管理“科学”的挑战——正确的结果衡量标准是什么?
The in vitro effect of N-acetylcysteine on prothrombin time in plasma samples from healthy subjects.
N-乙酰半胱氨酸对健康受试者血浆样本中凝血酶原时间的体外影响。
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    A. Pizon;D. Jang;Henry E. Wang
  • 通讯作者:
    Henry E. Wang
Carpometacarpal Dislocation of the Thumb
  • DOI:
    10.1016/j.jemermed.2007.10.083
  • 发表时间:
    2010-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anthony F. Pizon;Henry E. Wang
  • 通讯作者:
    Henry E. Wang

Henry E. Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Henry E. Wang', 18)}}的其他基金

Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest
院外心脏骤停气道管理的实用试验
  • 批准号:
    8793277
  • 财政年份:
    2014
  • 资助金额:
    $ 190.27万
  • 项目类别:
Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest
院外心脏骤停气道管理的实用试验
  • 批准号:
    8930251
  • 财政年份:
    2014
  • 资助金额:
    $ 190.27万
  • 项目类别:
Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest
院外心脏骤停气道管理的实用试验
  • 批准号:
    9116937
  • 财政年份:
    2014
  • 资助金额:
    $ 190.27万
  • 项目类别:
Risk Factors for Sepsis in the Community
社区败血症的危险因素
  • 批准号:
    8458902
  • 财政年份:
    2011
  • 资助金额:
    $ 190.27万
  • 项目类别:
Risk Factors for Sepsis in the Community
社区败血症的危险因素
  • 批准号:
    8840322
  • 财政年份:
    2011
  • 资助金额:
    $ 190.27万
  • 项目类别:
Risk Factors for Sepsis in the Community
社区败血症的危险因素
  • 批准号:
    8302201
  • 财政年份:
    2011
  • 资助金额:
    $ 190.27万
  • 项目类别:
Risk Factors for Sepsis in the Community
社区败血症的危险因素
  • 批准号:
    8192635
  • 财政年份:
    2011
  • 资助金额:
    $ 190.27万
  • 项目类别:
Effect of Paramedic Airway Experience on Patient Outcomes
护理人员气道经验对患者预后的影响
  • 批准号:
    7824725
  • 财政年份:
    2009
  • 资助金额:
    $ 190.27万
  • 项目类别:
Effect of Paramedic Airway Experience on Patient Outcomes
护理人员气道经验对患者预后的影响
  • 批准号:
    7740956
  • 财政年份:
    2006
  • 资助金额:
    $ 190.27万
  • 项目类别:
Effect of Paramedic Airway Experience on Patient Outcomes
护理人员气道经验对患者结果的影响
  • 批准号:
    7197718
  • 财政年份:
    2006
  • 资助金额:
    $ 190.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 190.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了